Stock ScreenerStock IdeasStrong Buys According to Wall StreetStrong Buys According to Wall StreetCompanies with high upside and a consensus strong buy recommendation from Wall Street analysts
Stock ScreenerStock IdeasStrong Buys According to Wall Street
Consensus: Strong Buy
Analysts: >= 3
Upside/Downside: Large Upside
| Ticker | Company | Market Cap | Price | Price Target | Upside/Downside | Top Analysts Upside/Downside | Consensus | Top Analysts Consensus | Analysts | Top Analysts | Fore. Revenue Growth | Fore. Earnings Growth | Forecast ROE | Forecast ROA |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| CATX | PERSPECTIVE THERAPEUTICS INC | $198.48M | $2.67 | $10.83 | 305.73% | Strong Buy | 6 | -16.17% | N/A | -35.45% | -29.13% | |||
| VTYX | VENTYX BIOSCIENCES INC | $584.43M | $8.19 | $14.60 | 78.27% | Strong Buy | 5 | N/A | N/A | -38.16% | -34.53% | |||
| MNPR | MONOPAR THERAPEUTICS | $498.55M | $74.61 | $106.20 | 42.35% | Strong Buy | 10 | N/A | N/A | -12.66% | -12.42% | |||
| NKLR | TERRA INNOVATUM GLOBAL NV | $400.72M | $5.70 | $16.33 | 186.54% | Strong Buy | 3 | N/A | N/A | N/A | -325.25% | |||
| OLMA | OLEMA PHARMACEUTICALS INC | $2.27B | $33.05 | $40.50 | 22.54% | Strong Buy | 6 | N/A | N/A | -54.66% | -47.69% | |||
| NTSK | NETSKOPE INC | $8.15B | $20.72 | $27.08 | 30.68% | Strong Buy | 13 | N/A | N/A | -83.14% | -7.32% | |||
| ZURA | ZURA BIO LTD | $261.39M | $4.02 | $11.50 | 186.07% | Strong Buy | 4 | N/A | N/A | -43.50% | -32.72% | |||
| RWT | REDWOOD TRUST INC | $709.42M | $5.60 | $6.90 | 23.21% | Strong Buy | 5 | -2.96% | N/A | 11.75% | 0.52% | |||
| PRCH | PORCH GROUP INC | $1.23B | $9.92 | $19.29 | 94.42% | Strong Buy | 7 | 6.44% | -29.43% | -155.14% | 5.50% | |||
| RAPP | RAPPORT THERAPEUTICS INC | $1.44B | $30.27 | $47.80 | 57.91% | Strong Buy | 5 | N/A | N/A | -35.63% | -34.05% | |||
| LUCK | LUCKY STRIKE ENTERTAINMENT CORP | $1.26B | $9.04 | $12.67 | 40.12% | Strong Buy | 3 | 5.59% | N/A | -10.77% | 1.09% | |||
| AVBP | ARRIVENT BIOPHARMA INC | $1.01B | $24.42 | $39.38 | 61.24% | Strong Buy | 8 | N/A | N/A | -3.66% | -3.42% | |||
| FUFU | BITFUFU INC | $469.42M | $2.86 | $6.13 | 114.16% | Strong Buy | 4 | 12.61% | -13.05% | 0.00% | 0.00% | |||
| DNTH | DIANTHUS THERAPEUTICS INC | $1.81B | $42.13 | $68.00 | 61.41% | Strong Buy | 8 | -12.57% | N/A | -37.08% | -35.09% | |||
| SSTI | SOUNDTHINKING INC | $96.38M | $7.59 | $16.50 | 117.39% | Strong Buy | 4 | 7.05% | N/A | -1.13% | -0.62% | |||
| CBIO | CRESCENT BIOPHARMA INC | $195.75M | $14.09 | $25.60 | 81.69% | Strong Buy | 5 | N/A | N/A | -49.00% | -41.34% | |||
| CNTA | CENTESSA PHARMACEUTICALS PLC | $3.56B | $26.51 | $39.57 | 49.27% | Strong Buy | 7 | N/A | N/A | -51.73% | -34.80% | |||
| VOYG | VOYAGER TECHNOLOGIES INC | $1.58B | $26.53 | $42.71 | 61.00% | Strong Buy | 7 | N/A | N/A | -5.04% | -4.09% | |||
| VNCE | VINCE HOLDING CORP | $46.69M | $3.50 | $4.50 | 28.57% | Strong Buy | 3 | 2.69% | N/A | 6.63% | 1.44% | |||
| TRVI | TREVI THERAPEUTICS INC | $1.64B | $12.77 | $21.63 | 69.34% | Strong Buy | 8 | N/A | N/A | -35.23% | -33.54% | |||
| KYTX | KYVERNA THERAPEUTICS INC | $384.53M | $8.78 | $25.33 | 188.53% | Strong Buy | 3 | N/A | N/A | -127.74% | -103.71% | |||
| OBIO | ORCHESTRA BIOMED HOLDINGS INC | $254.66M | $4.51 | $14.00 | 210.42% | Strong Buy | 4 | 1.92% | N/A | -84.93% | -35.44% | |||
| IVA | INVENTIVA SA | $426.65M | $4.46 | $17.83 | 299.84% | Strong Buy | 6 | 6.34% | N/A | N/A | -33.14% | |||
| SAIL | SAILPOINT INC | $11.81B | $21.03 | $25.36 | 20.61% | Strong Buy | 11 | 14.45% | N/A | 3.11% | 2.84% | |||
| COYA | COYA THERAPEUTICS INC | $129.31M | $6.18 | $15.80 | 155.66% | Strong Buy | 5 | 4.34% | N/A | -16.43% | -13.99% | |||
| JANX | JANUX THERAPEUTICS INC | $920.26M | $15.30 | $63.22 | 313.22% | Strong Buy | 9 | -33.76% | N/A | -24.81% | -23.64% | |||
| MPLT | MAPLIGHT THERAPEUTICS INC | $939.22M | $20.70 | $31.00 | 49.76% | Strong Buy | 4 | N/A | N/A | N/A | -71.49% | |||
| Q | QNITY ELECTRONICS INC | $16.54B | $78.94 | $100.67 | 27.52% | Strong Buy | 3 | N/A | N/A | 10.93% | 7.97% | |||
| PYPD | POLYPID LTD | $61.36M | $3.92 | $12.25 | 212.50% | Strong Buy | 4 | N/A | N/A | 15.60% | 8.47% | |||
| NUVL | NUVALENT INC | $7.62B | $104.80 | $134.29 | 28.14% | Strong Buy | 14 | N/A | N/A | -3.81% | -3.28% | |||
| MRP | MILLROSE PROPERTIES INC | $5.26B | $31.70 | $39.33 | 24.08% | Strong Buy | 3 | N/A | N/A | N/A | N/A | |||
| PRQR | PROQR THERAPEUTICS NV | $250.97M | $2.33 | $6.67 | 186.14% | Strong Buy | 3 | -17.95% | N/A | N/A | N/A | |||
| BRSL | BRIGHTSTAR LOTTERY PLC | $3.11B | $15.96 | $22.00 | 37.84% | Strong Buy | 4 | 1.08% | -18.65% | 14.66% | 2.14% | |||
| IFF | INTERNATIONAL FLAVORS & FRAGRANCES INC | $16.20B | $63.26 | $80.33 | 26.99% | Strong Buy | 9 | -0.27% | N/A | 9.90% | 5.47% | |||
| DCO | DUCOMMUN INC | $1.41B | $94.22 | $117.80 | 25.03% | Strong Buy | 5 | 5.81% | N/A | 12.22% | 6.35% | |||
| CRC | CALIFORNIA RESOURCES CORP | $4.04B | $48.32 | $62.71 | 29.79% | Strong Buy | 7 | 0.95% | -5.12% | 9.21% | 4.70% | |||
| JBIO | JADE BIOSCIENCES INC | $689.14M | $14.98 | $22.00 | 46.86% | Strong Buy | 4 | N/A | N/A | -49.84% | -44.15% | |||
| RVPH | REVIVA PHARMACEUTICALS HOLDINGS INC | $76.51M | $0.67 | $3.33 | 401.20% | Strong Buy | 6 | N/A | N/A | -180.56% | -57.32% | |||
| EVMN | EVOMMUNE INC | $567.75M | $18.01 | $39.33 | 118.40% | Strong Buy | 3 | N/A | N/A | N/A | N/A | |||
| PTRN | PATTERN GROUP INC | $2.24B | $12.72 | $19.89 | 56.36% | Strong Buy | 9 | N/A | N/A | 17.34% | 11.13% | |||
| LXEO | LEXEO THERAPEUTICS INC | $713.09M | $9.77 | $19.83 | 103.00% | Strong Buy | 6 | N/A | N/A | -74.24% | -62.37% | |||
| GPCR | STRUCTURE THERAPEUTICS INC | $4.06B | $67.06 | $97.11 | 44.81% | Strong Buy | 9 | N/A | N/A | -22.42% | -20.75% | |||
| SNTI | SENTI BIOSCIENCES INC | $34.44M | $1.31 | $10.33 | 688.78% | Strong Buy | 3 | N/A | N/A | -617.50% | -95.18% | |||
| VREX | VAREX IMAGING CORP | $488.31M | $11.71 | $16.67 | 42.33% | Strong Buy | 3 | 4.47% | N/A | 9.00% | 3.84% | |||
| VKTX | VIKING THERAPEUTICS INC | $4.19B | $37.08 | $95.86 | 158.51% | Strong Buy | 7 | N/A | N/A | -60.75% | -58.58% | |||
| DYN | DYNE THERAPEUTICS INC | $2.75B | $19.27 | $38.27 | 98.61% | Strong Buy | 11 | N/A | N/A | -41.45% | -33.07% | |||
| CMPS | COMPASS PATHWAYS PLC | $647.15M | $6.74 | $17.20 | 155.19% | Strong Buy | 5 | N/A | N/A | -336.09% | -49.43% | |||
| NXTC | NEXTCURE INC | $29.85M | $11.14 | $23.00 | 106.46% | Strong Buy | 3 | N/A | N/A | -38.61% | -23.05% | |||
| NRIX | NURIX THERAPEUTICS INC | $1.47B | $19.07 | $26.70 | 40.01% | Strong Buy | 10 | -11.52% | N/A | -64.73% | -46.12% | |||
| OVID | OVID THERAPEUTICS INC | $116.79M | $1.64 | $3.33 | 103.23% | Strong Buy | 3 | N/A | N/A | -64.46% | -45.13% | |||
| AMPL | AMPLITUDE INC | $1.50B | $11.25 | $15.43 | 37.15% | Strong Buy | 7 | 11.40% | N/A | 16.12% | 9.65% | |||
| ENOV | ENOVIS CORP | $1.51B | $26.47 | $50.40 | 90.40% | Strong Buy | 5 | 4.02% | N/A | 11.07% | 5.04% | |||
| BEP | BROOKFIELD RENEWABLE PARTNERS LP | $7.95B | $27.89 | $35.75 | 28.18% | Strong Buy | 8 | 3.52% | N/A | N/A | N/A | |||
| ORKA | ORUKA THERAPEUTICS INC | $1.46B | $30.18 | $49.57 | 64.25% | Strong Buy | 7 | N/A | N/A | -34.59% | -33.06% | |||
| CNTB | CONNECT BIOPHARMA HOLDINGS LTD | $139.76M | $2.50 | $8.67 | 246.68% | Strong Buy | 3 | N/A | N/A | -79.30% | -65.18% | |||
| RZLT | REZOLUTE INC | $166.91M | $1.80 | $13.00 | 622.22% | Strong Buy | 5 | N/A | N/A | -8.03% | -7.45% | |||
| ANGO | ANGIODYNAMICS INC | $541.37M | $13.14 | $19.33 | 47.13% | Strong Buy | 3 | 5.82% | N/A | 10.34% | 6.96% | |||
| PVLA | PALVELLA THERAPEUTICS INC | $1.17B | $98.58 | $142.69 | 44.75% | Strong Buy | 13 | N/A | N/A | -96.72% | -55.89% | |||
| ORIC | ORIC PHARMACEUTICALS INC | $913.51M | $9.38 | $19.50 | 107.89% | Strong Buy | 10 | N/A | N/A | -41.74% | -39.39% | |||
| ELVN | ENLIVEN THERAPEUTICS INC | $1.00B | $16.86 | $45.67 | 170.86% | Strong Buy | 3 | N/A | N/A | -28.48% | -27.62% | |||
| BCRX | BIOCRYST PHARMACEUTICALS INC | $1.59B | $7.57 | $19.25 | 154.29% | Strong Buy | 8 | 7.64% | N/A | -52.87% | 45.94% |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.